Drimva

Lila Sciences

Director, Enterprise Account Management, Life Sciences

$168K–$272K

Cambridge, MA USA +1 · Director · Full-time · Posted Oct 5, 2026

Location
Cambridge, MA USA
One Charles Park, Cambridge, MA
Experience
10+ years; no alternative stated.
Education
Degree in biology, chemistry, biochemistry, bioengineering, or adjacent fields, or equivalent experience.

About the job

Own and grow strategic top-20 pharmaceutical accounts, closing enterprise agreements for Lila Sciences’ AI and autonomous-lab platform.

What you'll do

  • Develop multi-year account strategies, build executive relationships, and lead complex pursuits through negotiation and close.
  • Forecast revenue, manage account risks, and coordinate with product, science, legal, finance, and procurement.
  • Shape enterprise commercial strategy and translate AI and life sciences developments into customer-facing narratives and deliverables.

What they ask for

  • 10+ years in enterprise sales, business development, or commercial leadership, including strategic-account ownership.
  • Track record closing large, multi-quarter enterprise agreements with top-20 pharma or comparable accounts.
  • Degree in biology, chemistry, biochemistry, bioengineering, or adjacent fields, or equivalent experience.
  • Fluency across the pharma R&D value chain and ability to communicate credibly with executive and technical buyers.

Nice to have

  • Working familiarity with AI and ML applied to life sciences.
  • Experience with pharma R&D buying cycles, frontier AI/biotech/platform companies, or early GTM playbook development.

Pay

$168,000 — $272,000 USD (base salary)

Tools

AI, AI and ML, autonomous labs, target identification, generative models, predictive ADMET, computational biology

AI focus

Sell and position AI and autonomous-lab capabilities for scientific discovery, small molecules, and biologics; translate their potential into scientific and commercial narratives.

Model-written summary · the original posting is authoritative

First seen Oct 10, 2026 · Last verified Nov 5, 2026 (UTC)